Hexaware and PointCross Unleash Game-Changing CDAaaS

In a groundbreaking initiative, Hexaware Technologies in collaboration with PointCross Life Sciences has launched Clinical Data Automation as a Solution (CDAaaS). This platform is set to revolutionize the clinical data management landscape, significantly enhancing efficiency and reducing costs. CDAaaS utilizes PointCross' Xbiom™ technology, targeting vital improvements across the clinical data lifecycle.

Introduction to CDAaaS by Hexaware and PointCross

The partnership between Hexaware Technologies and PointCross Life Sciences has birthed CDAaaS, a robust solution designed for the clinical trials sector. This new offering leverages Xbiom™, a platform known for its sophisticated data management and standardization capabilities. As industries grapple with inefficiencies in data handling and compliance requirements, CDAaaS promises to streamline processes from data collection to regulatory submission.

Key Features and Benefits of CDAaaS

CDAaaS offers a myriad of advanced features aimed at enhancing data accuracy and operational efficiency. Here are some of its key components:

• Automated Data Management: The platform automates all aspects of clinical data management, curation, and standardization, ensuring compliance with regulatory standards.
• Advanced Automation: Utilizing metadata repositories and smart transformers, CDAaaS simplifies data curation and increases the reliability of clinical trials data.
• Patient Insights: Highly configurable dashboards and data visualization tools are integrated within CDAaaS, aiding in rapid data analysis and medical monitoring.
• Cost and Time Efficiency: By efficiently managing electronic data capture (EDC) and lab queries, CDAaaS reduces both the cost and time required for comprehensive data analysis.

These features collectively aim to provide unparalleled operational advantages to BioPharma and BioTech companies.

Impact on the Clinical Trials Industry

The CDAaaS platform is poised to make significant inroads in the clinical trials industry by providing a faster, more cost-effective means for data management and submission. According to Srinivas Marimganti, Head of Life Sciences & Healthcare at Hexaware Technologies, the collaboration harnesses Hexaware's clinical expertise and PointCross' robust automation capabilities, delivering a cutting-edge solution that enhances data accuracy and compliance. The overarching goal is to facilitate quicker and more reliable outcomes, essential for advancing medical research and treatments.

The introduction of Clinical Data Automation as a Solution by Hexaware and PointCross marks a pivotal advancement in clinical data management. By simplifying complex processes and enhancing efficiency, CDAaaS stands to reshape the operational dynamics of the clinical trials industry. This innovative platform is not just a technical solution; it's a strategic tool that fosters faster, more reliable, and economically feasible research outcomes, ultimately accelerating the pace at which medical innovations can reach the market and benefit society.

Don't miss our latest Startup News: Huawei Elevates Enterprise Tech with Xinghe Campus